Enhancing the potency of 5T4 mRNA vaccine by CD70 mRNA-LNPs through ADCC and T cell boosting in prostate cancer therapy.
PubMed
2025/07/18 发表J NanobiotechnologyQ1 · IF 15(JCR 2025)
这些结果表明,这种联合 mRNA 疫苗策略可能为前列腺癌提供更有效且持久的治疗,并且 CD70 mRNA 作为一种免疫激活剂,在癌症免疫治疗中具有更广泛的潜力。